Significant enhancement of the gastric mucin production after rabeprazole administration: Its potential clinical significance in acid-related disorders

被引:0
|
作者
Skoczylas, T
Sarosiek, I
Sostarich, S
McElhinney, C
Durham, S
Sarosiek, J
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
S1271
引用
收藏
页码:A196 / A196
页数:1
相关论文
共 18 条
  • [1] Significant enhancement of gastric mucin content after rabeprazole administration - Its potential clinical significance in acid-related disorders
    Skoczylas, T
    Sarosiek, I
    Sostarich, S
    McElhinney, C
    Durham, S
    Sarosiek, J
    DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (02) : 322 - 328
  • [2] Significant Enhancement of Gastric Mucin Content After Rabeprazole Administration: Its Potential Clinical Significance in Acid-Related Disorders
    T. Skoczylas
    I. Sarosiek
    S. Sostarich
    C. McElhinney
    S. Durham
    J. Sarosiek
    Digestive Diseases and Sciences, 2003, 48 : 322 - 328
  • [3] Administration of rabeprazole results in restoration of naproxen-induced gastric mucin production impairment: Its significant clinical potential
    Jaworski, T
    Sarosiek, I
    Sostarich, S
    Roeser, K
    Connor, M
    Brotze, S
    Wallner, G
    Sarosiek, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S37 - S37
  • [4] Restorative Impact of Rabeprazole on Gastric Mucus and Mucin Production Impairment During Naproxen Administration: Its Potential Clinical Significance
    T. Jaworski
    I. Sarosiek
    S. Sostarich
    K. Roeser
    M. Connor
    S. Brotze
    G. Wallner
    J. Sarosiek
    Digestive Diseases and Sciences, 2005, 50 : 357 - 365
  • [5] Restorative impact of rabeprazole on gastric mucus and mucin production impairment during naproxen administration: Its potential clinical significance
    Jaworski, T
    Sarosiek, I
    Sostarich, S
    Roeser, K
    Connor, M
    Brotze, S
    Wallner, G
    Sarosiek, J
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (02) : 357 - 365
  • [6] Rabeprazole: a pharmacologic and clinical review for acid-related disorders
    Dadabhai, Alia
    Friedenberg, Frank K.
    EXPERT OPINION ON DRUG SAFETY, 2009, 8 (01) : 119 - 126
  • [7] Rabeprazole - An update of its use in acid-related disorders
    Carswell, CI
    Goa, KL
    DRUGS, 2001, 61 (15) : 2327 - 2356
  • [8] Rabeprazole - A review of its use in acid-related gastrointestinal disorders
    Langtry, HD
    Markham, A
    DRUGS, 1999, 58 (04) : 725 - 742
  • [9] Rabeprazole A Review of its Use in the Management of Gastric Acid-Related Diseases in Adults
    Baldwin, Claudine M.
    Keam, Susan J.
    DRUGS, 2009, 69 (10) : 1373 - 1401
  • [10] Significant Increase of Esophageal Mucin Secretion in Patients with Reflux Esophagitis After Healing with Rabeprazole: Its Esophagoprotective Potential
    Irene Sarosiek
    Mojtaba Olyaee
    Marek Majewski
    Elena Sidorenko
    Katherine Roeser
    Sandra Sostarich
    Grzegorz Wallner
    Jerzy Sarosiek
    Digestive Diseases and Sciences, 2009, 54 : 2137 - 2142